Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis

被引:25
|
作者
Ciurea, Alexandru Vlad [1 ,2 ]
Mohan, Aurel George [3 ,4 ]
Covache-Busuioc, Razvan-Adrian [1 ]
Costin, Horia-Petre [1 ]
Glavan, Luca-Andrei [1 ]
Corlatescu, Antonio-Daniel [1 ]
Saceleanu, Vicentiu Mircea [5 ,6 ]
机构
[1] Carol Davila Univ Med & Pharm, Dept Neurosurg, Bucharest 020021, Romania
[2] Sanador Clin Hosp, Neurosurg Dept, Bucharest 010991, Romania
[3] Bihor Cty Emergency Clin Hosp, Dept Neurosurg, Oradea 410167, Romania
[4] Oradea Univ, Fac Med, Dept Neurosurg, Oradea 410610, Romania
[5] Sibiu Cty Emergency Hosp, Neurosurg Dept, Sibiu 550245, Romania
[6] Lucian Blaga Univ Med, Neurosurg Dept, Sibiu 550024, Romania
关键词
molecular genetics; neurodegenerative disease; molecular pathology; epigenetics; gene expression; therapeutic targets; biomarkers; Alzheimer's disease; Parkinson's disease; Huntington's disease; amyotrophic lateral sclerosis; HEXANUCLEOTIDE REPEAT EXPANSION; HEREDITARY CEREBRAL-HEMORRHAGE; MOTOR-NEURON DEGENERATION; FRONTOTEMPORAL DEMENTIA; APOLIPOPROTEIN-E; MOUSE MODEL; TAU GENE; FUS GENE; A-BETA; NEUROFIBRILLARY TANGLES;
D O I
10.3390/ijms241310809
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative diseases are, according to recent studies, one of the main causes of disability and death worldwide. Interest in molecular genetics has started to experience exponential growth thanks to numerous advancements in technology, shifts in the understanding of the disease as a phenomenon, and the change in the perspective regarding gene editing and the advantages of this action. The aim of this paper is to analyze the newest approaches in genetics and molecular sciences regarding four of the most important neurodegenerative disorders: Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. We intend through this review to focus on the newest treatment, diagnosis, and predictions regarding this large group of diseases, in order to obtain a more accurate analysis and to identify the emerging signs that could lead to a better outcome in order to increase both the quality and the life span of the patient. Moreover, this review could provide evidence of future possible novel therapies that target the specific genes and that could be useful to be taken into consideration when the classical approaches fail to shed light.
引用
收藏
页数:41
相关论文
共 50 条
  • [1] Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis
    Dunkel, Petra
    Chai, Christina L. L.
    Sperlagh, Beata
    Huleatt, Paul B.
    Matyus, Peter
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (09) : 1267 - 1308
  • [2] Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis)
    Gaggelli, Elena
    Kozlowski, Henryk
    Valensin, Daniela
    Valensin, Gianni
    CHEMICAL REVIEWS, 2006, 106 (06) : 1995 - 2044
  • [4] Positron emission tomography neuroimaging in neurodegenerative diseases: Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis
    Barc, Krzysztof
    Kuzma-Kozakiewicz, Magdalena
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2019, 53 (02) : 99 - 112
  • [5] Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
    David Devos
    Z. Ioav Cabantchik
    Caroline Moreau
    Véronique Danel
    Laura Mahoney-Sanchez
    Hind Bouchaoui
    Flore Gouel
    Anne-Sophie Rolland
    James A. Duce
    Jean-Christophe Devedjian
    Journal of Neural Transmission, 2020, 127 : 189 - 203
  • [6] Iron as a therapeutic target for neurodegenerative diseases (Parkinson's disease and amyotrophic lateral sclerosis)
    Devos, D.
    Moreau, C.
    FEBS OPEN BIO, 2018, 8 : 33 - 33
  • [7] Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis
    Devos, David
    Cabantchik, Z. Ioav
    Moreau, Caroline
    Danel, Veronique
    Mahoney-Sanchez, Laura
    Bouchaoui, Hind
    Gouel, Flore
    Rolland, Anne-Sophie
    Duce, James A.
    Devedjian, Jean-Christophe
    Cassereau, Julien
    Bost, Marie
    Abrial, Charlotte
    Muller, Jeanne
    Olivier, Audrey
    Le Masson, Gwendal
    Mathis, Stephane
    Djigo, Dieynaba
    Bonabaud, Sarah
    Deloire, Mathilde
    Genestet, Steeve
    Menanteau, Elsa
    Bourgeois, Pauline
    Lefilliatre, Mathilde
    Viader, Fausto
    Abrou, Mouloud
    Chavanne, Damien
    Bari, Rachida
    Guy, Nathalie
    Arondo, Sophia Sickout
    Rouvet, Sandrine
    Beauvais, Katell
    Aidan, Mathilde
    Madec, Olivier
    Danel-Brunaud, Veronique
    Tard, Celine
    Pleuvret, Marie
    Santraine, Valerie
    Moutarde, Julie
    Couratier, Philippe
    Lautrette, Geraldine
    Machat, Selma
    Penoty, Marie
    Villeneuve, Olivier
    Labetoulle, Clemence
    Catteau, Julie
    Bernard, Emilien
    Svahn, Juliette
    Neuillet, Camille
    Attarian, Shahram
    JOURNAL OF NEURAL TRANSMISSION, 2020, 127 (02) : 189 - 203
  • [8] DHUNE: neurodegenerative diseases and aging euro - mediterranee solutions for neurodegenerative diseases (Parkinson's disease, Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis and others) and successful aging
    Blin, O.
    Otten, L.
    Dhune, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 69 - 70
  • [9] Selective diagnostics of Amyotrophic Lateral Sclerosis, Alzheimer's and Parkinson's Diseases with machine learning and miRNA
    Lee, Juhyeok
    Kouznetsova, Valentina L.
    Kesari, Santosh
    Tsigelny, Igor
    METABOLIC BRAIN DISEASE, 2025, 40 (01)
  • [10] Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases
    Perez-Olives, Catalina
    Rivas-Santisteban, Rafael
    Lillo, Jaume
    Navarro, Gemma
    Franco, Rafael
    CANNABINOIDS AND NEUROPSYCHIATRIC DISORDERS, 2021, 1264 : 81 - 92